NFKB1 and hepatocellular carcinoma: Recent studies have identified LIFR as a tumor suppressor gene in hepatocellular carcinoma, where it inhibits the NF-κB signaling pathway by interacting with SHP1, thereby altering the expression of the target gene LCN2 and modulating sensitivity to ferroptosis, suggesting a potential avenue for targeted induction of ferroptosis [39].